CIK 0000200406
- Large accelerated filer
JOHNSON & JOHNSON
Sign in to watch- Ticker
- JNJ
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Jan 3
- Incorporated
- NJ
- Entity type
- Operating
- EIN
- 221024240
- Phone
- +1 732-524-2455
- Business address
- ONE JOHNSON & JOHNSON PLZ, NEW BRUNSWICK, NJ, 08933
- Former names
- JOHNSON & JOHNSON ET AL
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $12,947,986
- in 2 filings
Net −$12,947,986. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-02-15 | REED JOHN C EVP, Innovative Medicine, R&D | Grant or award · Employee Stock Options (Right to Buy) | +65,163 | 65,163 | ||
| 2024-02-15 | REED JOHN C EVP, Innovative Medicine, R&D | Grant or award · Restricted Share Units | +4,048 | 4,048 | ||
| 2024-02-15 | Swanson James D. EVP, CIO | Grant or award · Employee Stock Options (Right to Buy) | +23,745 | 23,745 | ||
| 2024-02-15 | Swanson James D. EVP, CIO | Grant or award · Restricted Share Units | +1,475 | 1,475 | ||
| 2024-02-15 | Hait William EVP, Chief EI and Med Officer | Grant or award · Employee Stock Options (Right to Buy) | +34,696 | 34,696 | ||
| 2024-02-15 | Hait William EVP, Chief EI and Med Officer | Grant or award · Restricted Share Units | +2,155 | 2,155 | ||
| 2024-02-15 | Forminard Elizabeth Executive VP, General Counsel | Grant or award · Employee Stock Options (Right to Buy) | +46,406 | 46,406 | ||
| 2024-02-15 | Forminard Elizabeth Executive VP, General Counsel | Grant or award · Restricted Share Units | +2,883 | 2,883 | ||
| 2024-02-15 | Broadhurst Vanessa EVP, Global Corp Affairs | Grant or award · Employee Stock Options (Right to Buy) | +23,745 | 23,745 | ||
| 2024-02-15 | Broadhurst Vanessa EVP, Global Corp Affairs | Grant or award · Restricted Share Units | +1,475 | 1,475 | ||
| 2024-02-15 | Duato Joaquin CEO and Chairman of the Board | Grant or award · Employee Stock Options (Right to Buy) | +177,816 | 177,816 | ||
| 2024-02-15 | Duato Joaquin CEO and Chairman of the Board | Grant or award · Restricted Share Units | +11,046 | 11,046 | ||
| 2024-02-15 | Fasolo Peter Exec VP, Chief HR Officer | Grant or award · Employee Stock Options (Right to Buy) | +40,551 | 40,551 | ||
| 2024-02-15 | Fasolo Peter Exec VP, Chief HR Officer | Grant or award · Restricted Share Units | +2,519 | 2,519 | ||
| 2024-02-15 | Decker Robert J VP Corporate Controller | Grant or award · Employee Stock Options (Right to Buy) | +8,175 | 8,175 | ||
| 2024-02-15 | Decker Robert J VP Corporate Controller | Grant or award · Restricted Share Units | +1,016 | 1,016 | ||
| 2024-02-13 | Wengel Kathryn E EVP, Chief TO and Risk Officer | Option exercise | +651 | 82,598.87 | ||
| 2024-02-13 | Wengel Kathryn E EVP, Chief TO and Risk Officer | Shares withheld for taxes | −333 | $157.85 | $53K | 82,265.87 |
| 2024-02-13 | Wengel Kathryn E EVP, Chief TO and Risk Officer | Option exercise · Restricted Share Units | −651 | 1,302 | ||
| 2024-02-13 | Wolk Joseph J Exec VP, CFO | Option exercise | +1,780 | 69,663 |
Page 27 of 33 · 658 trades